Top Markets
#1 Akedo Akedo +61.77%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.05%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.60%
#6 Ο„emplar Ο„emplar +27.06%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.57%
#8 Bitway Bitway +17.22%
#9 Perle Perle +16.80%
#10 Cap Cap +16.64%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Universal Ibogaine Inc. Universal Ibogaine Inc.

Universal Ibogaine Inc.

IBO
Rank in Stocks #38208
Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating,... Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating, obtaining, and managing addiction treatment centers throughout Canada. The company is also actively involved in scheduled clinical trials, researching the efficacy of ibogaine as a treatment for addiction. Its operations are directed from its head office in Calgary, Canada.
Share Price
$0.00366968
Last synced: 2026-03-02
Market Cap
$1.13M
Change (1 day)
0.00%
Change (1 year)
-74.65%
Country
CA
Trade Universal Ibogaine Inc. (IBO)

Category

Healthcare
Revenue for Universal Ibogaine Inc. (IBO)
Revenue in Aug 2026 TTM: 0
According to Universal Ibogaine Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Universal Ibogaine Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE